Bibhudatta Mishra: A paradigm shift in oncology
Bibhudatta Mishra, Clinical Development Leader at Neuronity, shared a post on LinkedIn:Â
“Scientists at KAIST (Korea Advanced Institute of Science & Technology), led by Professor Kwang-Hyun Cho, have developed a groundbreaking cancer therapy that reprograms colon cancer cells into healthy ones instead of destroying them. This innovative approach uses advanced gene modeling to reverse cancer at the genetic level, minimizing damage to healthy tissues—unlike traditional treatments like chemotherapy and radiation.
Published in Advanced Science, this research marks a paradigm shift in oncology, offering a safer, more precise alternative to conventional therapies. By transforming cancer cells rather than eradicating them, this method could improve survival rates and reduce reliance on harsh drugs.
Indeed a breakthrough and a stepping stone for treating other cancers!!!!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023